Skip to content
stoqly

Oil States International, Inc

OIS NYSE Oil & Gas Field Machinery & Equipment Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$669M
3.4% vs prior year
Operating margin Operating income as a share of revenue.
βˆ’14.6%
14.4 pts
Net income Profit after all expenses, interest and tax.
βˆ’$109M
Free cash flow Cash from operations minus capital spending.
$73.9M
781.6%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
βˆ’15.3%
15.1 pts
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On βˆ’$1.84 EPS (TTM)

What Oil States International, Inc does

No business description yet.

Legal name
OIL STATES INTERNATIONAL, INC
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Mar 4, 2026
Accession Β· CIK
0001121484-26-000007
0001121484

Revenue and margins

Oil States International, Inc had $669M of revenue in fiscal 2025, down 3.4% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $73.9M in fiscal 2025, 11.1% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Oil States International, Inc returned $16.6M to shareholders in fiscal 2025, 22% of free cash flow. The diluted share count fell 5.3%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Oil States International, Inc can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $52.9M$42.0M$47.1M$65.4M$69.9M
Debt incl. finance leases $160M$135M$136M$125M$1.7M
Net debt / EBITDA 6.7x1.3x1.1x1.1xβ€”
Debt / equity 0.2x0.2x0.2x0.2x0.0x
Interest coverage βˆ’6.3x0.3x2.4xβˆ’0.2xβˆ’12.7x
Current ratio 2.4x2.4x3.1x3.2x1.9x
Quick ratio 1.5x1.4x1.8x1.8x1.2x
Total assets $1.1B$1.1B$1.0B$1.0B$883M
Total liabilities $390M$375M$337M$324M$310M
Shareholders' equity $696M$690M$710M$681M$573M
Net debt (βˆ’ = net cash) $108M$93.0M$88.4M$59.3Mβˆ’$68.2M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive βœ• βœ• βœ• βœ• βœ• βœ• βœ• βœ“ βœ• βœ•
Cash from operations is positive βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Return on assets rose β€” βœ• βœ“ βœ• βœ• βœ“ βœ“ βœ“ βœ• βœ•
Cash from operations exceeds net income βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Debt fell relative to assets β€” βœ“ βœ• βœ“ βœ• βœ• βœ“ βœ• βœ“ βœ“
Current ratio rose β€” βœ• βœ• βœ• βœ• βœ• βœ• βœ“ βœ“ βœ•
Share count didn't rise β€” βœ“ βœ• βœ• βœ• βœ• βœ• βœ• βœ“ βœ“
Gross margin rose β€” βœ• βœ“ βœ• βœ• βœ“ βœ“ βœ“ βœ“ βœ•
Revenue rose relative to assets β€” βœ“ βœ“ βœ“ βœ• βœ• βœ“ βœ“ βœ• βœ“
F-score β€” / 35 / 95 / 94 / 92 / 94 / 96 / 97 / 96 / 95 / 9
Accruals ratio βˆ’14.1%βˆ’13.4%βˆ’7.4%βˆ’19.8%βˆ’41.7%βˆ’6.4%βˆ’3.9%βˆ’4.1%βˆ’5.6%βˆ’22.7%
Altman Z'' 11.1911.015.494.311.323.834.445.325.303.50

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $694M $671M $1.1B $1.0B $638M $573M $738M $782M $693M $669M
Gross profit $406M $150M $254M $215M $76.3M $103M $159M $175M $156M $133M
Research and development β€” $5.3M $6.6M $7.0M $6.1M $4.4M $3.5M $4.5M $5.2M $5.1M
Operating income βˆ’$69.3M βˆ’$73.9M βˆ’$5.9M βˆ’$228M βˆ’$534M βˆ’$64.8M $2.9M $23.2M βˆ’$1.7M βˆ’$98.0M
Interest expense $5.3M $4.7M $19.3M $17.9M $14.3M $10.3M $10.6M $9.6M $8.8M $7.7M
Pretax income βˆ’$73.3M βˆ’$77.4M βˆ’$21.7M βˆ’$241M βˆ’$534M βˆ’$73.3M βˆ’$4.1M $15.8M βˆ’$7.9M βˆ’$103M
Income tax βˆ’$26.9M $7.4M βˆ’$2.6M βˆ’$8.9M βˆ’$65.9M βˆ’$9.3M $5.5M $2.9M $3.4M $6.8M
Net income βˆ’$46.4M βˆ’$84.9M βˆ’$19.1M βˆ’$232M βˆ’$468M βˆ’$64.0M βˆ’$9.5M $12.9M βˆ’$11.3M βˆ’$109M
Net income to common βˆ’$46.4M βˆ’$84.9M βˆ’$19.1M βˆ’$232M βˆ’$468M βˆ’$64.0M βˆ’$9.5M $12.6M βˆ’$11.3M βˆ’$109M
Diluted EPS βˆ’$0.92 βˆ’$1.69 βˆ’$0.33 βˆ’$3.90 βˆ’$7.83 βˆ’$1.06 βˆ’$0.15 $0.20 βˆ’$0.18 βˆ’$1.86
Diluted shares 0.05B 0.05B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B 0.06B
Cash flow
Cash from operations $149M $95.4M $103M $137M $133M $7.2M $32.9M $56.6M $45.9M $105M
Capital expenditure $29.7M $35.2M $88.0M $56.1M $12.7M $17.5M $20.3M $30.7M $37.5M $31.2M
Free cash flow $120M $60.2M $15.1M $81.3M $120M βˆ’$10.3M $12.6M $25.9M $8.4M $73.9M
Depreciation and amortization $119M $108M $124M $123M $98.5M $80.7M $67.3M $60.8M $54.7M $47.4M
Stock-based compensation $21.3M $23.0M $22.6M $16.8M $8.4M $7.9M $6.9M $7.0M $8.7M $7.7M
Acquisitions $0.0M $12.9M $380M $0.0M $0.0M $0.0M $8.1M $0.0M $0.0M β€”
Share buybacks $0.0M $16.3M $0.0M $0.8M $0.0M $0.0M $0.0M $6.9M $14.2M $16.6M
Dividends and buybacks $0.0M $16.3M $0.0M $0.8M $0.0M $0.0M $0.0M $6.9M $14.2M $16.6M
Balance sheet
Cash and short-term investments $68.8M $53.5M $19.3M $8.5M $72.0M $52.9M $42.0M $47.1M $65.4M $69.9M
Total debt $45.9M $5.3M $332M $248M $166M $160M $135M $136M $125M $1.7M
Current assets $490M $456M $534M $483M $424M $427M $463M $488M $498M $495M
Current liabilities $107M $115M $181M $183M $162M $177M $194M $157M $158M $266M
Inventory $175M $168M $209M $221M $170M $169M $183M $202M $215M $183M
Property and equipment, net $553M $499M $540M $460M $384M $339M $304M $280M $267M $244M
Goodwill $263M $268M $647M $482M $76.5M $76.4M $79.3M $79.9M $69.7M $70.5M
Intangible assets $52.7M $50.3M $255M $230M $206M $186M $170M $153M $126M $31.5M
Total assets $1.4B $1.3B $2.0B $1.7B $1.2B $1.1B $1.1B $1.0B $1.0B $883M
Total liabilities $180M $169M $564M $504M $395M $390M $375M $337M $324M $310M
Shareholders' equity $1.2B $1.1B $1.4B $1.2B $758M $696M $690M $710M $681M $573M
Margins
Gross margin 58.5% 22.3% 23.3% 21.1% 12.0% 17.9% 21.6% 22.4% 22.6% 19.9%
Operating margin βˆ’10.0% βˆ’11.0% βˆ’0.5% βˆ’22.4% βˆ’83.7% βˆ’11.3% 0.4% 3.0% βˆ’0.2% βˆ’14.6%
EBITDA margin 7.1% 5.0% 10.8% βˆ’10.3% βˆ’68.3% 2.8% 9.5% 10.7% 7.7% βˆ’7.6%
Net margin βˆ’6.7% βˆ’12.7% βˆ’1.8% βˆ’22.8% βˆ’73.4% βˆ’11.2% βˆ’1.3% 1.6% βˆ’1.6% βˆ’16.3%
FCF margin 17.2% 9.0% 1.4% 8.0% 18.8% βˆ’1.8% 1.7% 3.3% 1.2% 11.1%
Returns
Return on capital βˆ’4.6% βˆ’5.4% βˆ’0.3% βˆ’12.3% βˆ’49.6% βˆ’6.4% 0.3% 2.4% βˆ’0.2% βˆ’15.3%
Return on capital employed βˆ’5.4% βˆ’6.2% βˆ’0.3% βˆ’14.8% βˆ’54.0% βˆ’7.1% 0.3% 2.6% βˆ’0.2% βˆ’15.9%
Return on equity βˆ’3.9% βˆ’7.3% βˆ’1.5% βˆ’17.4% βˆ’47.3% βˆ’8.8% βˆ’1.4% 1.8% βˆ’1.6% βˆ’17.4%
Return on assets βˆ’3.4% βˆ’6.3% βˆ’1.2% βˆ’12.4% βˆ’32.5% βˆ’5.7% βˆ’0.9% 1.2% βˆ’1.1% βˆ’11.6%
Return on tangible equity βˆ’5.2% βˆ’10.4% βˆ’3.6% βˆ’45.3% βˆ’98.5% βˆ’14.8% βˆ’2.2% 2.7% βˆ’2.3% βˆ’23.2%
Growth
Revenue growth β€” βˆ’3.4% 62.3% βˆ’6.5% βˆ’37.3% βˆ’10.2% 28.7% 6.0% βˆ’11.5% βˆ’3.4%
Net income growth β€” β€” β€” β€” β€” β€” β€” β€” βˆ’187.3% β€”
EPS growth β€” β€” β€” β€” β€” β€” β€” β€” βˆ’190.0% β€”
FCF growth β€” βˆ’49.6% βˆ’74.8% 436.9% 47.6% βˆ’108.6% β€” 105.8% βˆ’67.6% 781.6%
Share count change β€” βˆ’0.1% 17.1% 1.1% 0.7% 0.8% 2.2% 2.5% βˆ’1.8% βˆ’5.3%
Financial health
Net debt / EBITDA βˆ’0.5x βˆ’1.4x 2.7x β€” β€” 6.7x 1.3x 1.1x 1.1x β€”
Debt / equity 0.0x 0.0x 0.2x 0.2x 0.2x 0.2x 0.2x 0.2x 0.2x 0.0x
Interest coverage βˆ’13.0x βˆ’15.8x βˆ’0.3x βˆ’12.7x βˆ’37.5x βˆ’6.3x 0.3x 2.4x βˆ’0.2x βˆ’12.7x
Current ratio 4.6x 4.0x 2.9x 2.6x 2.6x 2.4x 2.4x 3.1x 3.2x 1.9x
Quick ratio 2.9x 2.5x 1.8x 1.4x 1.6x 1.5x 1.4x 1.8x 1.8x 1.2x
Capital allocation
Capex / revenue 4.3% 5.2% 8.1% 5.5% 2.0% 3.1% 2.7% 3.9% 5.4% 4.7%
Stock comp / revenue 3.1% 3.4% 2.1% 1.6% 1.3% 1.4% 0.9% 0.9% 1.3% 1.2%
Payouts / FCF 0.0% 27.0% 0.0% 0.9% 0.0% β€” 0.0% 26.5% 169.5% 22.5%
Quality scores
Piotroski F-score β€” 5.0 5.0 4.0 2.0 4.0 6.0 7.0 6.0 5.0
Altman Z'' 11.2 11.0 5.5 4.3 1.3 3.8 4.4 5.3 5.3 3.5
Accruals ratio βˆ’14.1% βˆ’13.4% βˆ’7.4% βˆ’19.8% βˆ’41.7% βˆ’6.4% βˆ’3.9% βˆ’4.1% βˆ’5.6% βˆ’22.7%

Source: SEC EDGAR XBRL filings (CIK 0001121484). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open